Arteris, Inc. AIP
- Market cap
- $1.2B
- P/E
- 0.0×
Follow AIP
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 15.10 | 3.27 | 3.57 | 4.83 | 5.46 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | 27.57 | 21.77 | 8.08 | 10.70 | 19.85 |
High Price
|
|||
| — | — | — | — | 211 | 217 | 245 | 145 | 267 | 299 |
Employees
|
|||
| — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | 32 | 32 | 38 | 50 | 54 | 58 | 71 |
Revenue
|
|||
| — | — | — | 91.52% | 95.31% | 90.15% | 91.50% | 90.54% | 89.67% | 90.23% |
Gross Margin
|
|||
| — | — | — | 7 | (2) | (22) | (28) | (32) | (31) | (33) |
EBT
|
|||
| — | — | — | 22.17% | (7.02%) | (59.01%) | (54.63%) | (59.25%) | (53.94%) | (47.14%) |
EBT Margin
|
|||
| — | 0 | — | 5 | (3) | (23) | (27) | (37) | (34) | (35) |
Net Income
|
|||
| — | — | — | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Depreciation
|
|||
| — | — | — | 1.00 | 1.81 | 1.72 | 1.55 | 1.50 | 1.48 | 1.67 |
Revenue/Sh
|
|||
| — | — | — | 0.15 | (0.19) | (1.06) | (0.84) | (1.03) | (0.86) | (0.82) |
Earnings/Sh
|
|||
| — | — | — | 0.39 | 0.12 | (0.04) | (0.21) | (0.44) | (0.02) | 0.16 |
Cash Flow/Sh
|
|||
| — | — | — | 0.00 | (0.04) | (0.04) | (0.03) | (0.04) | (0.01) | (0.03) |
Capex/Sh
|
|||
| — | — | — | 0.39 | 0.09 | (0.07) | (0.24) | (0.48) | (0.03) | 0.13 |
Free CF/Sh
|
|||
| — | — | — | (0.12) | (0.68) | 2.41 | 1.15 | 0.42 | (0.03) | (0.35) |
Book Value/Sh
|
|||
| — | — | — | 32 | 18 | 22 | 33 | 36 | 39 | 42 |
Shares
|
|||
| — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | 11.40 | 11.40 | 12.25 | 2.71 | 3.72 | 6.87 | 9.29 |
PS Ratio
|
|||
| — | — | — | 0.00 | 0.00 | 8.77 | 3.64 | 13.23 | 0.00 | 0.00 |
PB Ratio
|
|||
| — | — | — | 11.09 | 11.09 | 10.01 | 1.39 | 3.02 | 6.15 | 8.54 |
EV/Sales
|
|||
| — | — | — | (185.96) | (185.96) | (233.73) | (8.96) | (9.40) | (339.82) | 112.73 |
EV/FCF
|
|||
| — | — | — | 12 | 2 | (1) | (7) | (16) | (1) | 7 |
Op' Cash Flow
|
|||
| — | — | — | 0 | (1) | (1) | (1) | (2) | 0 | (1) |
Capex
|
|||
| — | — | — | 12 | 2 | (2) | (8) | (17) | (1) | 5 |
FCF
|
|||
| — | — | — | 4 | 1 | 64 | 37 | 12 | 10 | 9 |
Working Cap'
|
|||
| — | — | — | 4 | 2 | 1 | 2 | 3 | 2 | 2 |
Total Debt
|
|||
| — | — | — | (10) | (10) | (85) | (66) | (38) | (42) | (53) |
Net Debt
|
|||
| — | — | — | (4) | (12) | 53 | 38 | 15 | (1) | (15) |
Sh' Equity
|
|||
| — | — | — | 34.43% | (9.37%) | (28.66%) | (23.21%) | (33.78%) | (32.20%) | (31.42%) |
ROA
|
|||
| — | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | (43.08%) | 30.41% | (114.36%) | (60.56%) | (140.09%) | (483.48%) | 439.27% |
ROE
|
|||
Arteris, Inc. peers in Semiconductors
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| POET POET Technologies Inc. | $1.4B | 0.0× | Compare |
| WOLF Wolfspeed, Inc. | $1.4B | 0.0× | Compare |
| CEVA Ceva, Inc. | $985.4M | 0.0× | Compare |
| AMBQ Ambiq Micro, Inc. | $1.7B | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| AOSL Alpha and Omega Semiconductor Limited | $826.4M | 0.0× | Compare |
| INDI indie Semiconductor, Inc. | $718.6M | 0.0× | Compare |
| LASR nLight | $2.4B | 0.0× | Compare |
| HIMX Himax Technologies, Inc. | $2.4B | 70.4× | Compare |
Arteris, Inc. (AIP) key facts
- Arteris, Inc. (AIP) is a Semiconductors company in the Technology sector, listed on Nasdaq.
- Arteris, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.6 million, up 22.3% from fiscal 2024.
- Arteris, Inc. reported a net loss of $34.7 million, or a loss of $0.82 per share, for fiscal 2025.
- As of September 25, 2026, AIP traded at $23.89, a market capitalization of $1.2 billion.
- Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 13.3× sales.
- Return on equity was 439.3% and debt-to-equity 0.05.
Arteris, Inc. (AIP) Latest News
22 Sep
AI-native chip design could eventually bypass Synopsys’ EDA tools, the bear case argued by Needham. Management counters that customers won’t approve chips without trusted sign-off tools and that AI agents will boost tool usage. Synopsys’ push includes Multiphysics Fusion and joint AI/physical design plans, plus royalties on Factory 2 in its IP business. Q3 2026 revenue rose 42% to $2.477 billion, helped by Ansys, which added about $711 million; core EDA grew 8.5%. Organic EDA growth is guided to double digits in Q4 2026 and the full year, though Ansys will continue to mask growth comparisons. The stock trades at roughly 75% of its 52-week high; investors will watch organic EDA trends as a potential early signal of AI-driven risk materializing. AI-driven design could dampen core EDA licensing demand, moderately impacting Arteris' IP business.
16 Sep
Arteris deploys FlexGen Multi-Die technology to advance its AI chiplet investment strategy. FlexGen Multi-Die adoption marks strategic move in AI chiplets likely to shift Arteris competitive trajectory and investor view.
15 Sep
Arteris accelerates the semiconductor industry's shift to multi-die chiplet-based architectures. Arteris drives adoption of multi-die chiplet architectures with direct effects on its technology positioning and growth outlook.
Arteris accelerates the industry transition to multi-die chiplet-based architectures. Promotion of multi-die chiplet architectures represents a major strategic move in semiconductor design.
13 Aug
Arteris (AIP) released its Q2 2026 earnings call transcript covering financial results, operations, and outlook. Quarterly earnings and guidance typically produce moderate short-term effects on valuation and sentiment.
7 Aug
Arteris Inc posted record annual contract value and 46% revenue growth in Q2 2026. Record ACV and 46% revenue surge signal strengthened financial trajectory and market position.
6 Aug
Arteris reported second quarter financial results, third quarter estimates and updated full year 2026 guidance. Quarterly results plus revised 2026 guidance can materially shift valuation and investor outlook.
Arteris Q2 earnings call highlights financial results, revenue figures, operational updates and future outlook for the company. Quarterly earnings updates typically influence short-term sentiment and specific financial metrics without major strategic shifts.
30 Jul
Arteris, Inc. (AIP) is scheduled to report earnings next week, with analysis focused on the likelihood of negative results and potential effects on the stock. Upcoming earnings report speculation may influence short-term stock sentiment but does not signal fundamental long-term changes.
21 Jul
Speedata has deployed Arteris technology for data center compute workloads. New design win in data center compute directly expands Arteris revenue opportunities and competitive positioning.
16 Jul
Oppenheimer states Arteris will benefit from AI-driven demand for NoC Interconnect IP. Analyst note on AI demand tailwinds can moderately lift Arteris sentiment and trajectory.
15 Jul
Arteris (AIP) may strengthen its competitive moat as Arm expands use of Cycuity Radix. Arm's expanded Cycuity Radix adoption could modestly improve Arteris market positioning.
Arteris partners with IC-Link to accelerate AI and HPC chip development. Partnership expands Arteris' reach in AI and HPC chip design tools.
Arteris Inc. partners with Arm to strengthen security in AI chips. Arm partnership bolsters Arteris AI chip security capabilities.
14 Jul
Arteris expands partnership with Arm to accelerate semiconductor cybersecurity. Partnership expansion with Arm strengthens Arteris semiconductor cybersecurity capabilities with moderate competitive upside.
8 Jul
Arteris partners with IC-Link by imec to accelerate next-gen AI and HPC silicon development. Collaboration strengthens Arteris position in AI and HPC chip design markets.
1 Jul
SiEngine Technology licensed Arteris Network-on-Chip interconnect IP. Licensing deal adds customer and revenue for Arteris core IP business.
Arteris stock reaches new all-time highs while positioned as resilient to tech market bubbles due to its business model and growth trajectory. Positive stock analysis at record highs can moderately lift near-term investor sentiment without altering fundamentals.
24 Jun
Arteris licensed its technology to SiEngine for next-generation automotive SoCs. Licensing agreement expands Arteris presence in automotive semiconductor segment.
28 May
Arteris outlines strategy targeting growth in AI, data centers and chiplets to reach $250M revenue. Revenue growth roadmap in AI data center and chiplet markets signals major strategic shift likely to lift valuation and investor outlook.
20 May
Arteris partners with Li Auto to integrate its AI chip interconnect technology into smart vehicle platforms for advanced automotive applications. Partnership with major EV maker Li Auto expands Arteris automotive AI footprint and revenue potential.
19 May
Arteris technology has been adopted by Li Auto for intelligent vehicles. Adoption by major EV maker Li Auto expands Arteris automotive semiconductor IP footprint and revenue prospects.
Li Auto adopts Arteris technology for intelligent vehicles. Li Auto adoption expands Arteris presence in automotive intelligent systems with potential revenue growth.
14 May
Arteris (AIP) shares rose 13.2% after the company raised its 2026 revenue guidance and reported Q1 results. Raising 2026 revenue guidance alongside Q1 results propelled a 13.2% stock surge, signaling major positive shifts in financial outlook and investor confidence.
13 May
Arteris (AIP) shares surged with strong momentum after robust earnings, prompting a detailed valuation assessment highlighting improved financial metrics and growth potential. Strong earnings triggered substantial share price momentum, significantly boosting investor sentiment and altering valuation trajectory.
Arteris Inc (AIP) reported record revenue for Q1 2026 alongside strategic acquisitions in earnings call highlights. Record revenue and strategic acquisitions represent major positive drivers for Arteris Inc's growth trajectory and investor sentiment.
12 May
Arteris, Inc. (AIP) Q1 2026 earnings call summary covers quarterly financial results, operational updates, and forward guidance. Q1 2026 earnings call summary reveals financial performance and strategic outlook likely to significantly sway investor sentiment and stock trajectory.
Arteris announced first-quarter financial results, second-quarter estimates, and updated full-year 2026 guidance. Quarterly results and revised full-year 2026 guidance significantly impact investor sentiment and stock trajectory.
Arteris, Inc. (AIP) released highlights from its Q1 earnings call, covering financial results, operational updates, and forward guidance. Q1 earnings highlights affect financial performance and investor sentiment but are balanced by quarterly nature and market factors.
Arteris, Inc. (AIP) reported a Q1 loss but beat revenue estimates. Quarterly revenue beat despite loss affects financial performance and investor sentiment moderately.